Another successful SUFU Foundation Preceptorship Program on the Books!
Thank you to the faculty and residents that made it a great weekend! read more »
SUFU Statement Regarding FDA Communication on “Vaginal Rejuvenation”
read more »
Announcing the SUFU Visiting Professorship
This 1-day visiting professorship will be offered to interested training programs and will consist of a lecture series from a member of the SUFU Executive Committee encompassing all aspects of FPMRS, Urodynamics, and Neurourology. read more »
Overactive Bladder Clinical (OAB) Care Pathway
SUFU is providing the Overactive Bladder Clinical Care Pathway for use by providers and patients. Overactive Bladder CCP Provider Flowchart »Overactive Bladder CCP Patient Roadmap » read more »
News & Announcements
  • Update: Important Message About FDA Statement on MUS On April 16, 2019, the U.S. Food and Drug Administration (FDA) issued an unexpected mandate recalling and halting the distribution of all remaining surgical mesh indicated for transvaginal (TV) repair of pelvic organ prolapse (POP), effective immediately.... [read more]
  • SUFU Update on FDA meeting On February 12th 2019, the FDA convened a meeting of the Obstetrics and Gynecology Medical Device Advisory Committee in Washington, D.C. to specifically address the safety and effectiveness of surgical mesh for transvaginal repair of pelvic organ prolapse in the anterior vaginal compartment. ... [read more]

View All